SELLAS Life Sciences Group Inc.

NASDAQ: SLS
Share price (1/3/25): $1.08
Market cap (1/3/25): $76.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 425 116 pages Agreement and Plan of Merger and Reorganization Among Galena Biopharma, Inc., Sellas Intermediate Holdings I, Inc., Sellas Intermediate Holdings II, Inc., Galena Bermuda Merger Sub, Ltd., and SELLAS Life Sciences Group Ltd Dated as of August 7, 2017

from 8-K 116 pages Agreement and Plan of Merger and Reorganization Among Galena Biopharma, Inc., Sellas Intermediate Holdings I, Inc., Sellas Intermediate Holdings II, Inc., Galena Bermuda Merger Sub, Ltd., and SELLAS Life Sciences Group Ltd Dated as of August 7, 2017

from 10-K 43 pages Unit Purchase Agreement

from S-1/A 11 pages Contribution Agreement Between Cytrx Corporation and Rxi Pharmaceuticals Corporation April 30, 2007

from S-1/A 19 pages Contribution Agreement by and Between Cytrx Corporation and Rxi Pharmaceuticals Corporation January 8, 2007

from S-1 4 pages January 8, 2007 Tod Woolf President Rxi Pharmaceuticals Corporation One Innovation Drive Worcester, Ma 01605 Re: Reimbursement of Fees and Expenses Dear Tod

from S-1 10 pages Contribution Agreement Between Cytrx Corporation and Rxi Pharmaceuticals Corporation April 30, 2007

from S-1 18 pages Contribution Agreement by and Between Cytrx Corporation and Rxi Pharmaceuticals Corporation January 8, 2007